Health
New staging system can inform treatment decisions for non-metastatic prostate cancer – News-Medical.Net
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.
Although it is one of the most common cancers worldwide, prostate cancer remains one of the few major cancers for which the familiar, numerical staging system -; ranging from stage 1 to stage 4 -; has not…
-
General14 hours agoPublisher ditches David Walliams after harassment claim
-
General12 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General11 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
General14 hours agoHow the Bondi shooters got access to now-banned guns